drugset / Trial / NCT03849196

Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG

NCT03849196

Completed 168 enrolled Samsung Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Proper bowel cleansing before colonoscopy is an important factor to increase the detection rate of lesions. Low volume polyethylene glycol (PEG) plus ascorbic (PEG-Asc) has reduced the dosage of previous bowel preparation agent, but it still presents discomfort to patients. The aim of this study was to confirm the efficacy and convenience of volume reduction of PEG-Asc by adding bisacodyl suppository at the same day by compared with conventional 2L PEG-Asc.

Timeline

Start
2017-07-31
Primary completion
2018-01-30
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 10 mg
Subject PEG-Asc Unknown 1000 ml
Subject PEG-Asc Unknown 2000 ml

Indications

No indication recorded.